Pharmaceutical composition for treating alzheimer disease
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for Alzheimer's disease and composition, applied in the field of medicine, to achieve the effect of increasing ACh content, reducing inflammation in the brain, and inhibiting the rate of apoptosis
Active Publication Date: 2015-05-13
南通大学技术转移中心有限公司
View PDF2 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0006] The technical problem to be solved by the present invention is to combine the traditional Chinese medicine theory and the clinical characteristics of Alzheimer's disease in traditional Chinese medicine, according
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0030] The preparation of embodiment 1 powder
[0031] Weigh 300g of Shouwu, 300g of Ganoderma lucidum, 200g of leeches, and 200g of Anemarrhena, add water and decoct twice, the first time for 2 hours, and the second time for 1.5 hours, combine the decoctions and let stand for precipitation, filter, and put the filtrate at 80°C Concentrate under reduced pressure to form a thick paste, dry below 80°C, pulverize, and sieve to obtain extract powder, add dextrin in an appropriate amount to dry, each g extract powder contains 2.5g of crude drug, and powder is obtained after crushing, the following "Yijing" Turn into turbid powder".
Embodiment 2
[0032] The preparation of embodiment 2 capsules
[0033] Weigh 300g of Shouwu, 200g of Ganoderma lucidum, 200g of leech, and 150g of Anemarrhena, add water and decoct twice, the first time for 2 hours, and the second time for 1.5 hours, combine the decoctions and let stand for precipitation, filter, and put the filtrate at 80°C Concentrate under reduced pressure to form a thick paste, dry below 80°C, pulverize, and sieve to obtain extract powder, add appropriate amount of auxiliary materials to dry, pulverize and put into gelatin capsules.
Embodiment 3
[0034] The preparation of embodiment 3 tablet
[0035] Weigh 100g of Shouwu, 100g of Ganoderma lucidum, 100g of leeches, and 150g of Anemarrhena, add water and decoct twice, the first time for 2 hours, and the second time for 1.5 hours, combine the decoctions and let stand for precipitation, filter, and put the filtrate at 80°C Concentrate under reduced pressure to form a thick paste, dry below 80°C, pulverize, and sieve to obtain extract powder, add appropriate amount of auxiliary materials, and press into tablets.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a pharmaceutical composition for treating alzheimer disease. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 1-5 parts of processed radix polygoni multiflori preparata, 1-5 parts of ganoderma lucidum, 1-2 parts of leech and 1-2 parts of rhizoma anemarrhenae. A prescription is formed by combining the traditional theory of the traditional Chinese medicine with the medical clinical characteristics of the alzheimer disease (AD) and the pharmacology research method. A pharmacological study proves that the pharmaceutical composition has multi-component, multi-target point and multi-way action characteristics on treatment of the AD. The pharmaceutical composition disclosed by the invention is capable of obviously improving learning and memory capabilities of a plurality of mice or rat models of AD, has an obvious anti-inflammatory effect, and is capable of relieving free radical injuries, improving self-energy metabolic disturbance in the brain, obviously inhibiting the apoptosis rate of hippocampal neurons of the AD rats, and playing roles in protecting nerves and resisting dementia by a central cholinergic system.
Description
technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a traditional Chinese medicine composition and its application for treating Alzheimer's disease. Background technique [0002] Alzheimer's disease (AD) is a degenerative disease of the central nervous system clinically characterized by progressive memory loss and dementia. With the extension of human life span, the incidence of AD has risen sharply. Due to the lack of effective treatment, AD has become the No. 4 killer of human beings after heart disease, cerebrovascular disease and cancer. Therefore, finding and developing drugs for the prevention and treatment of AD has become an urgent task, and research on the prevention and treatment of AD has become the primary research topic in the global medical community. [0003] The pathological features of AD are mainly senile plaques (senile plaques, SP), neurofibrillary tangles (neurofibrillary tangles, NFT) and neuro...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more